|
|
| Line 30: |
Line 30: |
| <span style="display:none">Pancreas</span> | | <span style="display:none">Pancreas</span> |
| <span style="display:none">Thymus gland</span> | | <span style="display:none">Thymus gland</span> |
| | <span style="display:none">isPatientAssociation</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | | <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> |
| <span style="display:none">isPatientAssociation</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C50: Breast cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forpatients francecountry
Go back to France page
Primary purpose: To provide support, assistance, and reassurance to laryngectomees, while challenging the perception of being mutilated, through activities such as visiting patients, training healthcare professionals, and creating a welcoming environment at their premises.
Cancer areas of interest: C00-C14: Mouth/throat cancers, C30-C39: Lung/chest cancers and C73-C75: Thyroid and other gland cancers. Click here to learn more.
Access to information: Click here to access.
Mouth
Throat
Oropharynx
Nasopharynx
Hypopharynx
Larynx
Salivary glands
Lips
Tonsils
base of tongue
Voice box
Lung
Trachea
Bronchi
Pleura
Mediastinum
Thyroid gland
Parathyroid
Adrenal glands
Pituitary gland
Pancreas
Thymus gland
isPatientAssociation
hasCancerType::C00-C14: Mouth/throat cancers
hasCancerType::C30-C39: Lung/chest cancers
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
